Highlights:
Talius Group Limited (ASX: TAL) has entered into a binding agreement for a $2.5 million placement of new shares to Stephen Norris Technologies Pty Ltd. The strategic placement involves the issuance of 286.05 million shares at $0.009 per share, representing a 7.7% premium to the 30-day volume-weighted average price (VWAP) of $0.0084 and a 12.5% premium to the last closing price of $0.008, as of 20 December 2024.
Capital Raise to Support Growth and Expansion
The proceeds from this placement, combined with the company's existing cash holdings, will be used to bolster Talius' expansion strategy, particularly focusing on scaling up its Home Care vertical. The funds will also help improve the company's capital management as it works toward achieving profitability in 2025. The strategic placement will significantly strengthen Talius' financial position and ensure its platform can support further growth.
Strategic Partnership and Industry Expertise
Stephen Norris Technologies Pty Ltd, led by Mr. Stephen Norris, brings over 40 years of experience in the aged care sector. Mr. Norris is the Managing Director of Lifestyle SA Group, a company with over 2,000 apartments across 11 retirement villages in South Australia. Norris is keen on leveraging his expertise in "ageing in place" solutions to drive improved outcomes for aged care providers and residents. This experience aligns with Talius' long-term vision, making him a valuable strategic investor.
MOU to Drive Future Collaborations
At the time of writing, a Memorandum of Understanding (MOU) is being finalized to explore strategic growth opportunities, including collaborations with companies like Lifestyle SA Group and CareWindow, an aged care communications platform. This partnership will enhance Talius' offerings while avoiding conflicts with larger operators in the sector. Additionally, upon completion of the placement, Mr. Norris will have the right to nominate a non-executive director to the Talius Board. This appointment is expected to be announced in early 2025.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Feb 21, 2025
Feb 21, 2025
Feb 20, 2025
Feb 20, 2025
Feb 20, 2025
Feb 18, 2025
Feb 18, 2025
Feb 18, 2025
Feb 17, 2025
Feb 17, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.